Saad Pharmaceuticals OÜ
Saad Pharmaceuticals OÜ is a OÜ based in Tallinn, registry code 16443544, status: in liquidation. Main activity: Manufacture of basic pharmaceutical products. Its annual report for 2025 shows revenue of €0 and 1 employees.
2025 · annual report, e-Äriregister
Position in the industry
- Revenue · 2025 0 €above 5% of companiesindustry median 48 003 € · companies in the industry: 19
Taxes and turnover
No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2026 | — | — | — | — | — | 1 |
| 2025 | 0 | 0 | 0 | 2 500 | 2 500 | 1 |
| 2024 | 0 | 0 | 0 | 2 500 | 2 500 | 1 |
| 2023 | 0 | 0 | 0 | 2 500 | 2 500 | 1 |
| 2022 | 0 | 0 | 0 | 2 500 | 2 500 | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 30 Jan 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 13 May 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 13 Jul 2024 | Company’s own | e-Äriregister |
| 2022 | 16 Feb 2022 – 31 Dec 2022 | 27 Feb 2023 | Company’s own | e-Äriregister |
Board
- Fawzy Ali SaadContact person · since 16 Jul 2024
- Fawzy Ali SaadLiquidator · since 19 May 2026
Owners
- Fawzy Ali SaadNatural person · 2 500 €
Beneficial owners
- Fawzy Ali SaadDirect ownership · UMI · since 16 Feb 2022
Founders and other persons
- Fawzy Ali SaadFounder · 2 500 € · 15 Feb 2022
Related companies
Activities (EMTAK)
- 21101Manufacture of basic pharmaceutical products Main
History of changes
| What | Value | Period |
|---|---|---|
| Status | In liquidation | 19 May 2026 – now |
| Status | Active | 16 Feb 2022 – now |
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50196702 / 7 19 May 2026 |
Termination entry | In force 19 May 2026 |
||
| Ä 50196702 / 6 16 Jul 2024 |
Amendment entry | In force 16 Jul 2024 |
||
| Ä 50196702 / 5 15 Jul 2024 |
Amendment entry | In force 15 Jul 2024 |
||
| Ä 50196702 / 4 3 Feb 2024 |
Amendment entry | In force 3 Feb 2024 |
||
| Ä 50196702 / 3 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50196702 / 2 8 Feb 2023 |
Amendment entry | In force 8 Feb 2023 |
||
| Ä 50196702 16 Feb 2022 |
First entry | In force 16 Feb 2022 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data